Aldevron News / Aldevron

Aldevron Names Matt Johnson Vice President of Information Technologies

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, announced the appointment of Matt Johnson as Vice President of Information Technologies (IT). In this newly-created executive role, Johnson will lead the IT team to ensure successful implementation and operation of key technology strategies.

Read More

Aldevron Names Shawn McCormick Chief Financial Officer

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteinstoday announced Shawn McCormick as its Chief Financial Officer. He will begin this new role immediately and will be a member of Aldevron’s executive team reporting to CEO Kevin Ballinger. 

Read More

Aldevron Promotes Venkata Indurthi to Vice President of Research and Development

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development (R&D).  He will begin this new role immediately and continue reporting to John Ballantyne, Co-founder and Chief Scientific Officer while having direct access to Aldevron’s senior executive team. 

Read More

Aldevron to Divest its Antibody Discovery Unit

Aldevron, a leading manufacturer of plasmid DNA, proteins and mRNA, today announced the sale of its Germany based antibody discovery businessBrian Walters, current president of the business unit and longtime employee of Aldevronled a group of investors to purchase the business for an undisclosed amount. The transaction is effective immediately.  

Read More

Aldevron The First To Rapidly Discover Human Antibodies Using Ligands Omnirat® Platform And Berkeley Lights Beacon® Instrument

Aldevron, a leading provider of antibody discovery and production services, today announced the successful discovery of human antibodies utilizing the combination of three powerful platforms, Aldevron’s GENOVAC® genetic immunization and cell-based screening, Ligand’s OmniRat® therapeutic antibody platform and Berkeley Lights’ Beacon® platform.

Read More

Aldevron's Antibody Discovery Team Participating at PEGS

Patricia Odermatt, Senior B-cell Scientist with Aldevron’s Antibody business unit, will be presenting at the  PEGS Boston Summit at 11:30 EDT on Monday, August 31. Her presentation,  Rapid Human Antibody Discovery Utilizing Ligand’s OmniRat® Platform and Berkeley Lights’ Beacon® Instrument will show how three antibody discovery platforms are being used together in developing fully human antibodies against SARS-CoV-2 targets. Patricia will be available at the Aldevron digital booth for additional discussions throughout PEGS. The presentation is only available to those registered for PEGS, which you can find here. However, anyone can connect with our Antibody team at any time through our contact form.
Read More